Literature DB >> 31803968

Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.

Raye Z Litten1, Daniel E Falk1, Megan L Ryan1, Joanne Fertig1, Lorenzo Leggio2,3,4.   

Abstract

Entities:  

Keywords:  Alcohol Use Disorder; Dissemination; Health Services; Medication Use; Medications; Personalized Medicine; Screening Models; Targets

Mesh：

Substances：

Year:  2019        PMID： 31803968     DOI： 10.1111/acer.14233

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN： 0145-6008            Impact factor:   3.455


× No keyword cloud information.
  6 in total

Review 1.  Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder.

Authors:  Falk W Lohoff
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

2.  Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder.

Authors:  Lara A Ray; Han Du; ReJoyce Green; Daniel J O Roche; Spencer Bujarski
Journal:  Neuropsychopharmacology       Date:  2020-11-24       Impact factor: 8.294

3.  Genetic variants associated with acamprosate treatment response in alcohol use disorder patients: A multiple omics study.

Authors:  Ming-Fen Ho; Cheng Zhang; Lixuan Wei; Lingxin Zhang; Irene Moon; Jennifer R Geske; Michelle K Skime; Doo-Sup Choi; Joanna M Biernacka; Tyler S Oesterle; Mark A Frye; Marvin D Seppala; Victor M Karpyak; Hu Li; Richard M Weinshilboum
Journal:  Br J Pharmacol       Date:  2022-02-08       Impact factor: 9.473

Review 4.  A meta-regression of methodological features that predict the effects of medications on the subjective response to alcohol.

Authors:  ReJoyce Green; Han Du; Erica N Grodin; Steven J Nieto; Spencer Bujarski; Daniel J O Roche; Lara A Ray
Journal:  Alcohol Clin Exp Res       Date:  2021-07-05       Impact factor: 3.928

Review 5.  Immune treatments for alcohol use disorder: A translational framework.

Authors:  Lindsay R Meredith; Elizabeth M Burnette; Erica N Grodin; Michael R Irwin; Lara A Ray
Journal:  Brain Behav Immun       Date:  2021-07-31       Impact factor: 19.227

6.  Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study.

Authors:  Joanna M Biernacka; Brandon J Coombes; Anthony Batzler; Ada Man-Choi Ho; Jennifer R Geske; Josef Frank; Colin Hodgkinson; Michelle Skime; Colin Colby; Lea Zillich; Sofia Pozsonyiova; Ming-Fen Ho; Falk Kiefer; Marcella Rietschel; Richard Weinshilboum; Stephanie S O'Malley; Karl Mann; Ray Anton; David Goldman; Victor M Karpyak
Journal:  Neuropsychopharmacology       Date:  2021-07-23       Impact factor: 7.853
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.